Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.

NCT00102128 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Stopped DMC recommended stop

Conditions

Ischemic Heart Failure
Ischemic Heart Disease
Ischemic Cardiomyopathy

Interventions

DRUG: Cellular Therapy (Cultured Autologous Skeletal Myoblast Transplantation)

Sponsor

Genzyme, a Sanofi Company